% | $
Quotes you view appear here for quick access.

NeuroMetrix Inc. Message Board

birdyvax 283 posts  |  Last Activity: 5 hours ago Member since: Feb 12, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Very interesting indeed... As were the comments on the seasonal & pandemic flu programs by biopronvax.

    The NVAX flu program is also 'Sleeping Giant.'

    Thanks for another great post Dirdammacondo.

  • Reply to

    Sleeping giant

    by nsat_992000 6 hours ago

    Thanks for the heads-up.
    Best quote: "Scared money don't make no money"
    Ain't that the truth...

    The Sleeping Giant is about to wake up and go on a bloody rampage. Starting as early as next week.

  • Reply to

    No Room for Fear

    by nutmeg_bull 21 hours ago
    birdyvax birdyvax 10 hours ago Flag

    "with an immediate focus on the RSV F Nanoparticle Vaccine in Older Adults"

    That says it all right there...

  • Reply to

    Hong Kong: RSV...

    by birdyvax Feb 5, 2016 10:20 AM
    birdyvax birdyvax Feb 5, 2016 10:34 AM Flag



  • birdyvax by birdyvax Feb 5, 2016 10:20 AM Flag

    RSV, flu A remain most prevalent fatal viruses in Hong Kong: study
    Source: Xinhua 2016-02-04 16:31:07 More
    HONG KONG, Feb. 4 (Xinhua) -- Respiratory syncytial virus (RSV) and influenza A are the most prevalent fatal types in Hong Kong among studied viruses, researchers from the Chinese University of Hong Kong said on Thursday.

    On analyzing more than 19,400 patients who were confirmed to have respiratory viral infections and admitted to the Prince of Wales Hospital in Sha Tin between 1998 and 2012, the researchers found that children and seniors were more likely to be affected by RSV and flu A.

    The findings showed that 37 percent of children aged five or below were infected with RSV and 25 percent with flu A. As for seniors aged 65 or above who died of respiratory infections, 48 percent were flu A and 20 percent were RSV.

    Professor Chan Kay Sheung, chairman of the university's Department of Microbiology, suggested hospitals to implement a rapid diagnostic test targeting RSV and flu A for patients with respiratory infection symptoms, especially for children and elderly people, which can help to provide early diagnosis and prompt treatment and reduce the risk of death.

    The researchers also encouraged breast feeding which can help strengthen infants' immune system, so as to lower the chance of RSV infections before one year old. Since influenza can cause serious infections, especially in those with chronic medial conditions, vaccination is a safe and effective way for prevention.

    The above results have been published in the November 2015 issue of the journal Medicine."

    How BIG the is the Chinese market for RSV??? HUGE. Good thing NVAX employees many many wonderful Chinese scientists and international business people. The red carpet will be rolled out for NVAX.
    How you say Resolve or Prepare in Chinese?

  • birdyvax birdyvax Feb 4, 2016 3:42 PM Flag

    This is Newer...
    The original patent app for RSV & Flu Combo was August 2014. (I posted on this in June 2015)
    Search: US20140227309
    Dated: August 14, 2014

    The sum of RSV & Flu is greater than the individual parts... Truly incredible and could literally change the industry. Who wouldn't choose an RSV/Flu combo vaccine over a basic flu vaccine?


  • birdyvax birdyvax Feb 4, 2016 3:39 PM Flag

    Interesting... This is NEW because the original patent app was August 14, 2014.
    NVAX is Stepping it Up!

    Here's my old post...
    birdyvax • Jun 26, 2015
    RSV & Flu Combo Vaccine... Check out the US Patent
    Search: US20140227309
    Dated: August 14, 2014

    Scroll down to "Summary of Invention." (My posts keep getting deleted on this...)

    The sum of RSV & Flu is greater than the individual parts... Truly incredible and could literally change the industry. Who wouldn't choose an RSV/Flu combo vaccine over a basic flu vaccine?"

  • Source: Avian Flu Diary 2/4/16

    NVAX is ready with its FDA Fast Tracked H7N9 vaccine.

    The Chinese government has a proven history of cover ups, so this is definitely something to keep an eye on.
    During the SARS outbreak, the Chinese authorities went so far as taking sick patients out of hospitals and hiding them in ambulances while the WHO was investigating. That's a fact.

  • G00GLE it... Very serious situation with suspected government cover up...

    Meanwhile, the Ukraine, Greece, Armenia, China, Puerto Rico, Ireland and other areas are also being hit at alarming levels of Swine Flu H1N1.

    The U.S. Has so far had a mild flu season but indications are that flu season is making a comeback and H1N1 will also be the predominant strain.

    Experts have predicted that the flu will peak in the U.S. in February this year. Super Bowl parties will add to the spread.

    As BioProNVAX alluded to... NVAX seasonal & pandemic flu vaccines are going to be superior.

  • Reply to


    by birdyvax Jan 28, 2016 8:00 PM
    birdyvax birdyvax Feb 4, 2016 11:23 AM Flag

    Interesting comments on the issue of toxicity from MainlyLobster...

    "She (biopronvax) said it is a question to ask if cloning a protein from an insect cell infecting virus would interfere with production in an insect expression system. She did not predict it, she suggested it to be a question to answer.

    This is similar conceptually to growing bird strains of flu in eggs. But in fact it is nothing like that and there is a very low chance it will be an issue. Why? Because what NVAX has is an insect cell adapted 'virus stock' that can be altered to insert small fragments of surface proteins from 'other viruses i.e. zika in this case.

    But this assumes (and this is a huge assumption) that the fragment of the surface protein is responsible for toxicity in the host cell. This in fact is quite unlikely to be the case as in most cases the NVAX vaccines are cloned to express only fragments of target proteins and two, fragments of proteins seldom carry their functional mechanisms of the whole proteins toxicity. How often would a fragment of a surface protein result in toxicity for the expression host system. Rare."

    This gives me hope that NVAX can still produce a Zika vaccine. Others companies may appear to be in the lead but remember the Ebola experience...

    Ebola fizzled but ZIKA may not.

  • birdyvax birdyvax Feb 4, 2016 11:07 AM Flag

    There are always those that vote NO and have different opinions.
    The ACIP vote for Prevnar was 13-2
    To think that there's not a chance anyone would vote NO is simply delusional.
    A 13-2 vote is a slam dunk...

  • birdyvax birdyvax Feb 4, 2016 10:00 AM Flag

    It will happen like this...

    Headline: 'U.S. advisory panel recommends Resolve vaccine for elderly'

    The Advisory Committee on Immunization Practices (ACIP), in a 13-2 vote, recommended that elderly patients take NVAX's vaccine.


    That's why we have Gail B on board...

  • Many people seem to think that because Hillary & Bernie want to cut down on 'price gouging' of big pharmaceutical drugs, that they are also anti-vaccine.

    Nothing could be further than the Truth. Both happen to be extremely Pro-Vaccine. Check out this the video (Lobster's old company IDB is mentioned)... READ the tweet by HC...

    (Replace 2 DOTs)

    BTW... This is not a political post or an endorsement. Just stating the facts. More pressure may be put on the pharmaceutical industry but it's all about over-priced DRUGS, not VACCINES. Vaccines are the FUTURE.

    Could you imagine Bernie Sanders as POTUS, pitching Novavax's, RSV Resolve for the elderly?
    "Come on people, everyone needs to take Resolve... this is not rocket science here."

  • birdyvax birdyvax Feb 4, 2016 8:45 AM Flag

    Nice post Kewi. Facts are facts... Here's another:

    "Nobody has ever been able to show that an RSV vaccine works in the elderly,” says Stanley Erck, Novavax’s CEO.

    That's the reason Big Pharma doesn't utter a word about RSV Elderly... Because they can't. If they could, RSV would be the next ED.

    NVAX is about to OWN a multi Billion Dollar space... RSV Elderly - RESOLVE.

  • Reply to

    The Wisdom of Jwilbanks...

    by birdyvax Jan 18, 2016 5:00 PM
    birdyvax birdyvax Feb 3, 2016 11:23 AM Flag

    Massive volume on DDXS today... Was jwilbanks right after all???

    LOL!!! Go Bengals! LOL!!! Too F_ing funny.

  • It's F_ing Ugly...
    - The markets are getting crushed...Biotech and Pharma are really getting crushed.
    - NVAX's latest offering seems like a hedge fund special. Even LuckyJack doesn't like it.
    - IR / NVAX isn't talking to us. Zero response.
    - NVAX will likely not have a seat at the Zika table...

    Then again...
    - NVAX has full support of the FDA for the fully enrolled Ph3 RSV franchise, worth Billions.
    - Prevnar has proven the huge & growing demand for adult respiratory vaccines.
    - H1N1 Flu is back and about to punch America in the face... Focus will be on next gen flu vaccines.
    - NVAX seasonal & pandemic flu vaccines expected to be better than even expected.
    - Matrix-M has been kicking but with GNCA, H7N9, and could be called to help with Zika vaccines.
    - We will have a major European partner in the very near future. Stan said so himself many times.
    - Stan & NVAX have under-promised & over-delivered... Again.
    - There's likely a good reason for the offering and also the silence of NVAX. (Material happenings.)
    - Stan said it's going to be a very exciting year... When has Stan ever been wrong on a call like this?
    - Ph3 Elderly completion later this year. 1st Company in history! HUGE. Monopoly for Resolve.
    - $89M grant from BMGF... Most influential group on the planet for vaccines.
    - 400 Dedicated super stars ready to roll at NVAX. All the pieces are in place.
    - Backing of BARDA for seasonal & Pandemic program.
    - How many millions of cash on hand now???

    I'll wait this one out. Tough times don't last...


  • birdyvax birdyvax Feb 2, 2016 9:10 AM Flag

    I believe it's, $155 or so per dose.

  • "About 9,000 schools and more than 1,600 kindergartens have been placed in quarantine in Russia due to the flu outbreak spreading across the country, a spokesperson for Russia’s public health watchdog Rospotrebnadzor said on Tuesday.

    MOSCOW (Sputnik) – The spokesperson told RIA Novosti that "8,891 school and 1,688 kindergartens are closed. In some cases, groups and classes are closed in preschool institutions."
    As of Friday, Russia’s Ministry of Healthcare confirmed 126 flu-related deaths in the country as the outbreak continues to spread across many regions of Russia, with a growing number of swine flu cases.

    Swine flu, an H1N1 subtype of the influenza A virus, carries a higher fatality risk than the common flu. Pregnant women, diabetics and obese people are at high-risk of susceptibility to the virus."

    In related news, the CDC announced yesterday, that 'severe' flu H1N1, is starting to spread in the U.S.

    With super bowl parties this weekends... Wash your hands and no double-dipping!

  • As Stan has said many times, Novavax's RSV is a Prevnar like opportunity. The demand for Prevnar among the elderly has been strong and growing. Novavax will soon have a monopoly on the RSV elderly market and older adults will Resolve to protect themselves from RSV the same way they are getting vaccinated with Prevnar and for seasonal flu. Remember, Stan has also said that NVAX expects RSV to be the largest selling vaccine in the history of vaccines.

  • Reply to

    WHO declares Zika a threat globally.

    by ctbnfo Feb 1, 2016 1:43 PM
    birdyvax birdyvax Feb 1, 2016 6:09 PM Flag

    Lobster, Thanks for the additional clarity. What do you think the chances are that NVAX is, or will soon attempt to create a Zika vaccine candidate? I know this (Zika virus), is something that you consider highly important.. (Me too).

    As I'm sure you know... The Sanofi Dengue vaccine offers no cross-protection against the Zika virus so the need for a Zika vaccine is of paramount importance.

    If you say that NVAX can't do it, I'll stop posting about it.


1.46-0.10(-6.41%)Feb 5 4:00 PMEST